References
- 1. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49(1):15-28. DOI: 10.1007/s15010-020-01509-1
- 2. Myrstad M, Ihle-Hansen H, Tveita AA, Andersen EL, Nygård S, Tveit A, et al. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study. Scand J Trauma Resusc Emerg Med. 2020;28(1):66. DOI: 10.1186/s13049-020-00764-3
- 3. Guarino M, Perna B, Remelli F, Cuoghi F, Cesaro AE, Spampinato MD, et al. A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA. Microorganisms. 2022;10(4):806. DOI: 10.3390/microorganisms10040806
- 4. Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision Trees: An Overview and Their Use in Medicine. J Med Syst. 2002;26(5):445-63. DOI: 10.1023/A:1016409317640
- 5. Karthikeyan A, Garg A, Vinod PK, Priyakumar UD. Machine Learning Based Clinical Decision Support System for Early COVID-19 Mortality Prediction. Front Public Heal. 2021;9:626697. DOI: 10.3389/fpubh.2021.626697
- 6. Wang K, Zuo P, Liu Y, Zhang M, Zhao X, Xie S, et al. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China. Clin Infect Dis. 2020;71(16):2079-88. DOI: 10.1093/cid/ciaa538
- 7. McCormik K, Salcedo J. Peck J. WA. SPSS Statistics for Data Analysis and visualization. Indianapolis, IN: John Wiley & Sons, Inc. 2017:355-92.
- 8. Hsu M. Structural Equation Modeling with IBM SPSS Amos. In: IBM Corporation, editor. IBM Software Business Analytics. Somers NY; 2010.
- 9. Barclay D., Higgins C, Thompson R. The Partial Least Squares (PLS) Approach to Causal Modeling: Personal Computer Adoption and Use as an Illustration. Technol Stud. 1995;2(2):285-309.
- 10. Hair, Jr., J.F., Hult, G.T.M., Ringle, C.M., Sarstedt, M., Danks, N.P., Ray, S. Partial least squares structural equation modeling (PLS-SEM) using R - a workbook, SPRINGER, 2021. DOI: 10.1007/978-3-030-80519-7
- 11. Khabaza T. 9 Laws of Data Mining [Internet]. 2010 [cited 2023 Apr 17]. Available from: http://khabaza.codimension.net/index_files/9laws.htm
- 12. Jöreskog KG, Wold H. The ML and PLS technique for modeling eith latent variables: historical and comparative aspects. In Wold H, Jöreskog KG (Eds.) Systems under indirect observations, part I. Amsterdam, North - Holland. 1982:263-270.
- 13. Prozan L, Shusterman E, Ablin J, Mitelpunkt A, Weiss-Meilik A, Adler A, et al. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. Sci Rep. 2021;11(1):21519. DOI: 10.1038/s41598-021-00927-x
- 14. Cîțu C, Gorun F, Motoc A, Sas I, Gorun OM, Burlea B, et al. The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality. Diagnostics. 2022;12(1):122. DOI: 10.3390/diagnostics12010122
- 15. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-12. DOI: 10.1016/j.jinf.2020.04.002
- 16. Önal U, Gülhan M, Demirci N, Özden A, Erol N, Işık S, et al. Prognostic value of neutrophile-to-lymphocyte ratio (NLR) and lactate dehydrogenase (LDH) levels for geriatric patients with COVID-19. BMC Geriatr. 2022;22(1):1-6. DOI: 10.1186/s12877-022-03059-7
- 17. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8. DOI: 10.1093/cid/ciaa248
- 18. Pál K, Molnar AA, Hu.anu A, Szederjesi J, Branea I, Timár Á, et al. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. Int J Mol Sci. 2022;23(18):10423. DOI: 10.3390/ijms231810423
- 19. Guan X, Zhang B, Fu M, Li M, Yuan X, Zhu Y, et al. Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study. Ann Med. 2021;53(1):257-66. DOI: 10.1080/07853890.2020.1868564
- 20. Andrijevic I, Matijasevic J, Andrijevic L, Kovacevic T, Zaric B. Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia. Ann Thorac Med. 2014;9(3):162-7. DOI: 10.4103/1817-1737.134072
- 21. Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21(6):337-9. DOI: 10.1038/s41577-021-00553-8
- 22. Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol. 2017;13:399-409. DOI: 10.1038/nrrheum.2017.83
- 23. Guirao JJ, Cabrera CM, Jiménez N, Rincón L, Urra JM. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19. Mol Immunol. 2020;128:64-8. DOI: 10.1016/j.molimm.2020.10.006
- 24. Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37. DOI: 10.1186/s41232-020-00146-3
- 25. Hirano T, Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020;52(5):731-3. DOI: 10.1016/j.immuni.2020.04.003
- 26. Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, et al. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology. Oxford Open Immunol. 2020;1(1):iqaa005. DOI: 10.1093/oxfimm/iqaa005
- 27. Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evidence-Based Med. 2021;26(3):107-8. DOI: 10.1136/bmjebm-2020-111536
- 28. Kodavoor Vadiraj P, Thareja S, Raman N, Karantha SC, Jayaraman M, Vardhan V. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19? J Clin Exp Hepatol. 2022;12(4):1114-23. DOI: 10.1016/j.jceh.2022.01.004
- 29. Pozzobon FM, Perazzo H, Bozza FA, Rodrigues RS, de Mello Perez R, Chindamo MC. Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil. Hepatol Int. 2021;15(2):493-501. DOI: 10.1007/s12072-021-10141-6
- 30. Parohan M, Yaghoubi S, Seraji A. Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies. Hepatol Res. 2020;50(8):924-35. DOI: 10.1111/hepr.13510
- 31. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. 1988;8(2):385-401. DOI: 10.1002/hep.1840080234
- 32. Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y, et al. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 2020;92(10):2152. DOI: 10.1002/jmv.26003
- 33. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-55. DOI: 10.1001/jamainternmed.2020.3539
- 34. Leulseged TW, Hassen IS, Ayele BT, Tsegay YG, Abebe DS, Edo MG, et al. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country. PLoS One. 2021;16(3): e0246087. DOI: 10.1371/journal.pone.0246087
- 35. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. DOI: 10.1001/jama.2020.1585
- 36. Nadim MK, Forni LG, Mehta RL, Connor MJ, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747-764. DOI: 10.1038/s41581-020-00356-5
- 37. Fabrizi F, Alfieri CM, Cerutti R, Lunghi G, Messa P. COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Pathogens. 2020;9(12):1-16. DOI: 10.3390/pathogens9121052
- 38. Yildirim C, Ozger H S, Yasar E, Tombul N, Gulbahar O, et al. Early predictors of acute kidney injury in COVID-19 patients. Nephrology (Carlton). 2021;26(6), 513-521. DOI: 10.1111/nep.13856
- 39. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38. DOI: 10.1016/j.kint.2020.03.005
- 40. Ley C, Martin RK, Pareek A, Groll A, Seil R, Tischer T. Machine learning and conventional statistics: making sense of the differences. Knee Surgery, Sport Traumatol Arthrosc. 2022;30(3):753-7. DOI: 10.1007/s00167-022-06896-6
- 41. Rakotomalala R. Arbres de Décision. Rev Modul. 2005;33:163-87.
- 42. Cole DA, Preacher KJ. Manifest variable path analysis: Potentially serious and misleading consequences due to uncorrected measurement error. Psychol Methods. 2014;19(2):300-15. DOI: 10.1037/a0033805